11-20-18 Urine Drug Screening, Dr. Jonathan Fellers

Maine Quality Counts podcast

Content provided by Emily Mullen and Maine Quality Counts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Emily Mullen and Maine Quality Counts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

5+ y ago 1:01:58

MP4•Episode home

Archived series ("Inactive feed" status)

When? This feed was archived on November 06, 2019 01:15 (4+ y ago). Last successful fetch was on September 17, 2019 13:18 (4+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Dr. Fellers is a native Mainer. He completed his undergraduate studies in chemistry at MIT before attending Cornell University Medical College. During his psychiatry residency at the University of Virginia, he gained clinical research experience recruiting, running, and managing medication trials that use the human laboratory for the evaluation of medications for substance use disorders. Dr. Fellers further developed his clinical and research skills during an addiction Psychiatry fellowship at Oregon Health & Sciences University and a postdoctoral training fellowship at the Portland VA healthcare System.

Since his return to Maine in 2015, Dr. Fellers has led the development and implementation of several successful programs in response to the State’s opioid epidemic. The MMC IMAT Program provides addiction consultations for patients hospitalized due to serious medical complications of drug use, such as endocarditis and epidural abscesses. The MMP IMAT Program delivers Medication-Assisted Treatment with buprenorphine within all primary care practices. The MaineHealth/MBH IMAT Program builds on the success of these previous initiatives to deploy evidence-based addiction services across the entire MaineHealth footprint.

97 episodes

#Af4q #Behavioralhealthhomes #Choosingwisely #Communitycareteams #Healthcare #Maine #Patientcenteredmedicalhome #Quality #Emily Mullen #Maine Quality Counts #Health and Well-Being #Podcasting Education #Improv